The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Molecular similarity: a key technique in molecular informatics
Abstract
Molecular Informatics utilises many ideas and concepts to find relationships between molecules. The concept of similarity, where molecules may be grouped according to their biological effects or physicochemical properties has found extensive use in drug discovery. Some areas of particular interest have been in lead discovery and compound optimisation. For example, in designing libraries of compounds for lead generation, one approach is to design sets of compounds "similar" to known active compounds in the hope that alternative molecular structures are found that maintain the properties required while enhancing e.g. patentability, medicinal chemistry opportunities or even in achieving optimised pharmacokinetic profiles. Thus the practical importance of the concept of molecular similarity has grown dramatically in recent years. The predominant users are pharmaceutical companies, employing similarity methods in a wide range of applications e.g. virtual screening, estimation of absorption, distribution, metabolism, excretion and toxicity (ADME/Tox) and prediction of physicochemical properties (solubility, partitioning etc.). In this perspective, we discuss the representation of molecular structure (descriptors), methods of comparing structures and how these relate to measured properties. This leads to the concept of molecular similarity, its various definitions and uses and how these have evolved in recent years. Here, we wish to evaluate and in some cases challenge accepted views and uses of molecular similarity. Molecular similarity, as a paradigm, contains many implicit and explicit assumptions in particular with respect to the prediction of the binding and efficacy of molecules at biological receptors. The fundamental observation is that molecular similarity has a context which both defines and limits its use. The key issues of solvation effects, heterogeneity of binding sites and the fundamental problem of the form of similarity measure to use are addressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cortes, C., & Vapnik, V. (1995) · Machine Learning · doi:10.1007/bf00994018 · Cited by 59,421
The Nature of Statistical Learning Theory
Vapnik, V. N. (1995) · doi:10.1007/978-1-4757-2440-0 · Cited by 39,138
Tversky, A. (1977) · Psychological Review · doi:10.1037/0033-295x.84.4.327 · Cited by 7,414
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
Handbook of Molecular Descriptors
Todeschini, R., & Consonni, V. (2000) · Methods and Principles in Medicinal Chemistry · doi:10.1002/9783527613106 · Cited by 4,107
Cramer, R. D., Patterson, D. E., & Bunce, J. D. (1988) · Journal of the American Chemical Society · doi:10.1021/ja00226a005 · Cited by 3,931
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Goodford, P. J. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00145a002 · Cited by 2,634
Étude comparative de la distribution florale dans une portion des Alpes et du Jura
Jaccard, P. (1901) · E-Periodica · doi:10.5169/seals-266450 · Cited by 2,353
Klebe, G., Abraham, U., & Mietzner, T. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00050a010 · Cited by 1,816
Cited by
Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations?
Bajusz, D., Rácz, A., & Héberger, K. (2015) · Journal of Cheminformatics · doi:10.1186/s13321-015-0069-3 · Cited by 1,621
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
Galloway, W. R. J. D., Isidro-Llobet, A., & Spring, D. R. (2010) · Nature Communications · doi:10.1038/ncomms1081 · Cited by 891
Similarity-based virtual screening using 2D fingerprints
Willett, P. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.005 · Cited by 849
Virtual Screening Strategies in Drug Discovery: A Critical Review
Lavecchia, A., & Giovanni, C. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990001 · Cited by 686
QSAR Applicability Domain Estimation by Projection of the Training Set in Descriptor Space: A Review
Jaworska, J., Nikolova-Jeliazkova, N., & Aldenberg, T. (2005) · Alternatives to Laboratory Animals · doi:10.1177/026119290503300508 · Cited by 682
Molecular Similarity in Medicinal Chemistry: Miniperspective
Maggiora, G., Vogt, M., Stumpfe, D., & Bajorath, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401411z · Cited by 666
Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches
Eckert, H., & Bajorath, J. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.01.011 · Cited by 466
Recognizing Pitfalls in Virtual Screening: A Critical Review
Scior, T., Bender, A., Tresadern, G., Medina-Franco, J. L., Martínez-Mayorga, K., Langer, T., Cuanalo-Contreras, K., & Agrafiotis, D. K. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200528d · Cited by 438
Self-citationOptimizing Fragment and Scaffold Docking by Use of Molecular Interaction Fingerprints
Marcou, G., & Rognan, D. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci600342e · Cited by 408
SwissSimilarity: A Web Tool for Low to Ultra High Throughput Ligand-Based Virtual Screening
Zoete, V., Daina, A., Bovigny, C., & Michielin, O. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00174 · Cited by 404
Computer-Assisted Retrosynthesis Based on Molecular Similarity
Coley, C. W., Rogers, L., Green, W. H., & Jensen, K. F. (2017) · ACS Central Science · doi:10.1021/acscentsci.7b00355 · Cited by 402
Novel Data-Mining Methodologies for Adverse Drug Event Discovery and Analysis
Harpaz, R., DuMouchel, W., Shah, N. H., Madigan, D., Ryan, P., & Friedman, C. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.50 · Cited by 393
Open-source platform to benchmark fingerprints for ligand-based virtual screening
Riniker, S., & Landrum, G. A. (2013) · Journal of Cheminformatics · doi:10.1186/1758-2946-5-26 · Cited by 359
Integrating high-content screening and ligand-target prediction to identify mechanism of action
Young, D. W., Bender, A., Hoyt, J., McWhinnie, E., Chirn, G.-W., Tao, C. Y., Tallarico, J. A., Labow, M., Jenkins, J. L., Mitchison, T. J., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.2007.53 · Cited by 345
Self-citationSpring, D. R. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b310752n · Cited by 347
Computational/in silico methods in drug target and lead prediction
Agamah, F. E., Mazandu, G. K., Hassan, R., Bope, C. D., Thomford, N. E., Ghansah, A., & Chimusa, E. R. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbz103 · Cited by 328
Bender, A., Scheiber, J., Glick, M., Davies, J. W., Azzaoui, K., Hamon, J., Urban, L., Whitebread, S., & Jenkins, J. L. (2007) · ChemMedChem · doi:10.1002/cmdc.200700026 · Cited by 327
Self-citationUltrafast shape recognition to search compound databases for similar molecular shapes
Ballester, P. J., & Richards, W. G. (2007) · Journal of Computational Chemistry · doi:10.1002/jcc.20681 · Cited by 327
Lama, L., Adura, C., Xie, W., Tomita, D., Kamei, T., Kuryavyi, V., Gogakos, T., Steinberg, J. I., Miller, M., Ramos-Espiritu, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08620-4 · Cited by 303
Bender, A., Jenkins, J. L., Scheiber, J., Sukuru, S. C. K., Glick, M., & Davies, J. W. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci800249s · Cited by 294
Self-citationComputational Prediction of Metabolism: Sites, Products, SAR, P450 Enzyme Dynamics, and Mechanisms
Kirchmair, J., Williamson, M. J., Tyzack, J. D., Tan, L., Bond, P. J., Bender, A., & Glen, R. C. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200542m · Cited by 289
Self-citationKoutsoukas, A., Simms, B., Kirchmair, J., Bond, P. J., Whitmore, A. V., Zimmer, S., Young, M. P., Jenkins, J. L., Glick, M., Glen, R. C., et al. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.05.011 · Cited by 287
Self-citationDiversity-oriented synthesis; a spectrum of approaches and results
Spandl, R. J., Bender, A., & Spring, D. R. (2008) · Organic & Biomolecular Chemistry · doi:10.1039/b719372f · Cited by 281
Self-citationAn overview of molecular fingerprint similarity search in virtual screening
Muegge, I., & Mukherjee, P. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1117070 · Cited by 277
Chemogenomic approaches to rational drug design
Rognan, D. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707307 · Cited by 269
Bender, A., & Cortes-Ciriano, I. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.11.037 · Cited by 232
Self-citationKrasowski, M. D., Drees, D., Morris, C. S., Maakestad, J., Blau, J. L., & Ekins, S. (2014) · BMC Clinical Pathology · doi:10.1186/1472-6890-14-33 · Cited by 212
Generative machine learning for de novo drug discovery: A systematic review
Martinelli, D. D. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105403 · Cited by 177
van Westen, G. J. P., Wegner, J. K., IJzerman, A. P., van Vlijmen, H. W. T., & Bender, A. (2011) · MedChemComm · doi:10.1039/c0md00165a · Cited by 176
Self-citationBender, A., Jenkins, J. L., Glick, M., Deng, Z., Nettles, J. H., & Davies, J. W. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci600197y · Cited by 110
Self-citationCombination therapeutics in complex diseases
He, B., Lu, C., Zheng, G., He, X., Wang, M., Chen, G., Zhang, G., & Lu, A. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12930 · Cited by 112
Effectiveness of molecular fingerprints for exploring the chemical space of natural products
Boldini, D., Ballabio, D., Consonni, V., Todeschini, R., Grisoni, F., & Sieber, S. A. (2024) · Journal of Cheminformatics · doi:10.1186/s13321-024-00830-3 · Cited by 97
Decatransin, a novel natural product inhibiting protein translocation at the Sec61/SecY translocon
Junne, T., Wong, J., Studer, C., Aust, T., Bauer, B. W., Beibel, M., Bhullar, B., Bruccoleri, R., Eichenberger, J., Estoppey, D., et al. (2015) · Journal of Cell Science · doi:10.1242/jcs.165746 · Cited by 67
Leveraging Cheminformatics Strategies for Inorganic Discovery: Application to Redox Potential Design
Janet, J. P., Gani, T. Z. H., Steeves, A. H., Ioannidis, E. I., & Kulik, H. J. (2017) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.7b00808 · Cited by 56
Shrivastava, A. D., & Kell, D. B. (2021) · Molecules · doi:10.3390/molecules26072065 · Cited by 25
Metadata
- Authors
- Bender, A., & Glen, R. C.
- Venue
- Organic & Biomolecular Chemistry
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2004
- Volume
- 2
- Issue
- 22
- Pages
- 3204
- ISSN
- 1477-0520 (ISSN-L)
- 1477-0539
- OpenAlex
- W2320034101
- Cited by
- 614
- References
- 105
- FWCI
- 26.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.